Why the study?
What clinical factors predict blood pressure reduction after catheter-based renal denervation in patients with resistant hypertension?
What clinical factors predict blood pressure reduction after catheter-based renal denervation in patients with resistant hypertension?
Answers are grounded in this paper and cite their sources.
Catheter-based renal denervation provides sustained blood pressure reduction at 3 years in a majority of patients with resistant hypertension, with specific clinical factors predicting better response.
INTRODUCTION: Renal denervation (RD) can lead to a significant and sustained decrease in mean values of arterial blood pressure (BP). However, there is still a subset of patients without a significant BP drop after RD (non-responders). AIM: To compare characteristics of RD responders to RD non-responders and to identify the clinical predictors of BP reduction. MATERIAL AND METHODS: Thirty-one patients with diagnosed resistant hypertension underwent RD. Three years after RD the analysis of BP reduction was performed in regard to the baseline patient characteristics. RESULTS: in 86%. Comorbidity included CAD in 50% and cardiomyopathy in 13% of patients. CONCLUSIONS: A 10% reduction of systolic baseline BP was observed in 74% of patients 3 years after renal denervation. Clinical factors like COPD, chronic kidney disease 3a, female sex and hypercholesterolemia increase the chances of effective reduction of BP.
No takes yet. Share an insight, caveat, or question.
Bartuś et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: